Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Iterum Therapeutics
Iterum Therapeutics
(ITRM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Annual sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Probenecid
pyelonephritis
,
pharmacokinetics
,
urinary tract infections
,
infections
,
intraabdominal infections
,
communicable diseases
,
cystitis
Sulopenem etzadroxil
pyelonephritis
,
pharmacokinetics
,
urinary tract infections
,
infections
,
intraabdominal infections
,
communicable diseases
,
cystitis
Sulopenem
renal insufficiency
,
pneumonia
,
bacterial pneumonia
Clavulin
infections
,
urinary tract infections
,
intraabdominal infections
,
communicable diseases
,
cystitis
Lactams
neoplasms
,
recurrence
,
non-hodgkin lymphoma
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
macular degeneration
,
wet macular degeneration
,
choroidal effusions
,
infections
,
communicable diseases
,
bacterial infections
,
methicillin-resistant staphylococcus aureus
,
staphylococcal skin infections
,
infectious skin diseases
,
bacterial skin diseases
,
cellulitis
Fluoroquinolone
healthy volunteers/patients
Hidroxicloroquina
prostatic neoplasms
Clavamox
pneumonia
,
community-acquired infections
,
bacterial pneumonia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use